rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Universe Pharmaceuticals Inc - Class A

UPC · Nasdaq

Health CarePharmaceuticalsJust dropped out

UPC stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 1.1% below that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just dropped out
Weeks in an uptrend
out for 1
Industry in uptrend
31% -7 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
3

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

17 Apr – 16 Oct
26%36%46%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders3
New · exited3 · 0
Reported value$125K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
UBS Group AGnew · filed 13 Aug 202614,367$88K+14,367
OSAIC HOLDINGS, INC.new · filed 14 Aug 20266,172$38K+6,172
Caitong International Asset Management Co., Ltdnew · filed 5 Aug 202612$73+12
31 Mar 2023 – 30 Jun 2026
023Mar 23Mar 25Jun 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Gang Lai Company insiderChief Executive Officer · last 7 May 20260 · 0

Same industry

ABBV AbbVieLeading+20%
VTRS ViatrisLeading+16%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 30 Sep 202535.3%
Operating profit marginFY 2025 · to 30 Sep 2025-16.3%
Free cash flow marginFY 2025 · to 30 Sep 2025-29.8%
Return on capital employedFY 2025 · to 30 Sep 2025-5.2%
Debt to equityFY 2025 · to 30 Sep 20250.04×
Interest coverFY 2025 · to 30 Sep 2025-10.08×
Research spendFY 2025 · to 30 Sep 20253.8%
Revenue growthFY 2024 · to 30 Sep 2024-28.7%
Share count trendFY 2024 · to 30 Sep 2024-98.8%
Cash and equivalentsFY 2025 · to 30 Sep 2025$33.6B
Free cash flowFY 2025 · to 30 Sep 2025−$5.3B

Analyst forecasts

No analyst forecasts yet.